Mutational evidence for a common kappa antagonist binding pocket in the wild-type kappa and mutant mu[K303E] opioid receptors

J Med Chem. 1998 Dec 3;41(25):4911-4. doi: 10.1021/jm9805182.
No abstract available

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Binding, Competitive
  • COS Cells
  • Guanidines
  • Guinea Pigs
  • Ileum / drug effects
  • In Vitro Techniques
  • Male
  • Mice
  • Models, Molecular
  • Molecular Conformation
  • Molecular Sequence Data
  • Morphinans
  • Muscle, Smooth / drug effects
  • Mutation
  • Naltrexone / analogs & derivatives*
  • Naltrexone / chemical synthesis
  • Naltrexone / metabolism
  • Naltrexone / pharmacology
  • Narcotic Antagonists / chemical synthesis*
  • Narcotic Antagonists / metabolism
  • Narcotic Antagonists / pharmacology
  • Rats
  • Receptors, Opioid, kappa / antagonists & inhibitors*
  • Receptors, Opioid, kappa / metabolism
  • Receptors, Opioid, mu / genetics*
  • Receptors, Opioid, mu / metabolism*
  • Vas Deferens / drug effects

Substances

  • 17-cyclopropylmethyl-6,7-didehydro-4,5-epoxy-5'-guanidinyl-3,14-dihydroxyindolo(2',3'-6,7)morphinan
  • CNGN-TI compound
  • Guanidines
  • Morphinans
  • Narcotic Antagonists
  • Receptors, Opioid, kappa
  • Receptors, Opioid, mu
  • norbinaltorphimine
  • Naltrexone